The END Fund (B)

Name: The END Fund (B) (English version)
SKU: 523064

Rangan, V. Kasturi; Han, Courtney

Product #:523064

Supplier:Harvard Business School

Discipline:Strategy

Setting:2021

Details:Supplemental Case (PDF) • 2 pages • 2023-01-10 (Rev: 2024-09-26)

Subjects:

Strategy Strategy

Your Price:

$7.50

Purchase this material with a free Educator Account and enjoy more benefits:

Free Educator Copy
Free Teaching Notes
Build your coursepack
Discounted academic price

Founded in 2012, the END fund focused on eliminating five Neglected Tropical Diseases that accounted for 80% of the tropical diseases affecting nearly 1.5 billion people worldwide. Its roughly $25 million/year annual budget was fully committed when it got news that the British Government would be cutting back its funding for the sector, putting at risk nearly 50,000 people for a tropical disease (visceral leishmaniasis-VL), which the End Fund was currently not addressing. The case question is whether the End Fund should redirect its resources to VL. The case highlights the difficult decisions that noprofits have to make balancing resource stretch and mission focus.

Learning Objectives

The case is aimed at addressing how to manage the key tensions between keeping a focus on the mission versus stretching an organization's resources to address an important neglected area not central, but related, to the mission. The case also has a second important learning objective of understanding how new sources of funding are balanced and targeted to address mission specific goals. A third learning goal is to introduce students to the topic of how one might approach achieving impact at scale.